WKSWA
NVO

White Knight Strategic Wealth Advisors’s Novo Nordisk NVO Stock Holding History

White Knight Strategic Wealth Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712K Buy
14,848
+2,395
+19% +$103K 0.5% 47
2026
Q1 		$458K Sell
12,453
-1,938
-13% -$91.8K 0.39% 52
2025
Q4 		$732K Buy
+14,391
New +$736K 0.54% 41

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

White Knight Strategic Wealth Advisors's NVO Position: Q2 2026 in Review

White Knight Strategic Wealth Advisors increased its Novo Nordisk (NVO) stake by 19% in Q2 2026, buying an estimated $103K and bringing the position to 14,848 shares worth $712K. The position accounts for 0.5% of the portfolio, ranked #47.

White Knight Strategic Wealth Advisors first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. The position peaked at $732K in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • White Knight Strategic Wealth Advisors held 14,848 shares of Novo Nordisk worth $712K as of Q2 2026.
  • White Knight Strategic Wealth Advisors bought 2,395 Novo Nordisk shares in Q2 2026, an estimated $103K.
  • Novo Nordisk made up 0.5% of White Knight Strategic Wealth Advisors's portfolio in Q2 2026, its #47 holding.
  • White Knight Strategic Wealth Advisors first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • White Knight Strategic Wealth Advisors's Novo Nordisk position peaked at $732K in Q4 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on White Knight Strategic Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.